Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
腫瘍抗原発現組換えポックスウイルス及び免疫チェックポイント分子アンタゴニストまたはアゴニストを用いた癌治療のための併用療法
Document Type and Number:
Japanese Patent JP6747981
Kind Code:
B2
Abstract:
The invention relates to compositions, kits, and methods for cancer therapy using recombinant poxviruses encoding a tumor-associated antigen in combination with antagonists or agonists of immune checkpoint inhibitors.

Inventors:
Foy Susan
Mandle Stephanie
Roundley Liang
Franz Sof Alex
Application Number:
JP2016567370A
Publication Date:
August 26, 2020
Filing Date:
May 08, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Bavarian Nordic Actiselskab
International Classes:
A61K35/76; A61K39/00; A61K39/395; A61K45/00; A61P35/00
Domestic Patent References:
JP2006340714A
Other References:
Cancer Immunol. Immunother.,2012年,Vol.61,pp.19-29
Proc. Natl. Acad. Sci. USA,2010年,Vol.107,pp.4275-4280
Biotechnol. Appl. Biochem.,2004年,Vol.39,pp.313-318
OncoImmunology,2012年,Vol.1 No.7,pp.1-2
日経メディカル Oncology ニュース,2011年,URL,https://medical.nikkeibp.co.jp/leaf/all/search/cancer/news/201111/522495.html&pr=1
Attorney, Agent or Firm:
Mitsufumi Esaki
Blacksmith
Katsunori Uenishi
Ichiro Torayama